Loading...
NPI 1235367467 · Munster, IN · Ophthalmology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Ruchita Amin is a ophthalmology physician provider located in Munster, Indiana. This profile covers 15 Medicare and 6 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Ruchita Amin |
| Address | 931 Ridge Rd Ste H |
| City | Munster |
| State | IN |
| ZIP | 46321 |
| Taxonomy | Ophthalmology Physician |
| NPI Enumerated | June 25, 2009 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.1M |
| Medicaid | $71K |
Business/service-line: The provider’s Medicare mix is dominated by intravitreal anti-VEGF therapies and high-complexity office visits, with J0178 (aflibercept) reported as 1.4K claims, $695 avg paid/claim, $948K revenue and J2777 (faricimab) at 24K claims, $29 avg paid/claim, $696K revenue. Combined with substantial volumes of 92134 retinal imaging (2.1K claims) and 67028 vitreous injections (1.4K claims), this pattern is consistent with a retina-focused ophthalmology practice that delivers frequent injectable therapies plus diagnostic imaging and evaluation-and-management visits.
Revenue concentration (Medicare): The top three Medicare codes (J0178, J2777, 99214) account for 86.1% of this provider’s Medicare revenue, indicating very high revenue concentration in a small set of services. That concentration suggests the practice’s Medicare financial performance is heavily reliant on continued use and reimbursement of these injection and E/M services.
Revenue concentration (Medicaid): On the Medicaid side, 67028, 99214, and 92134 together account for 90.3% of this provider’s Medicaid revenue, with 67028 alone generating $37.6K (53.1% of Medicaid revenue). Medicaid revenue is therefore also tightly concentrated around intravitreal injections, imaging, and E/M visits.
Payer mix and scale: This provider is effectively Medicare-dominant in scale, with total Medicare revenue of $2.1M versus total Medicaid revenue of $71K. The disparity in magnitude indicates Medicare accounts for the vast majority of billed revenue and market activity for this clinician.
Competitive standing (Medicare): For its highest-revenue Medicare services the provider is generally a modest-to-strong participant: J0178 ranks #924 of 3204 (71th percentile, typical), J2777 ranks #415 of 2039 (80th percentile, typical), and 67028 ranks #935 of 4255 (78th percentile, typical). However, the provider is an extreme national outlier on 99214 (rank #1052 of 479517, 100th percentile), indicating unusually high volume of moderate-complexity established-patient E/M visits relative to peers.
Competitive standing (Medicaid/in-state): In Medicaid billing this provider is not a dominant in-state player for injections or imaging: 67028 ranks #41 of 55 providers in-state (26th percentile) and 92134 ranks #47 of 84 (45th percentile), indicating modest to mid-level participation compared with Indiana peers. Medicaid E/M volume (99214) is also mid-range in state ranking (rank #1367 of 2122, 36th percentile).
Service-pattern outliers and utilization notes: Several diagnostic and documentation codes are reported at notably high national percentiles despite representing small revenue shares—92134 is at the 96th percentile and 92202 is an extreme outlier at the 98th percentile—signaling above-typical use of retinal imaging and extended ophthalmoscopy relative to most peers. These utilization patterns may reflect clinical preference or a practice workflow that emphasizes imaging and detailed retinal exam documentation in addition to injections.
Tenure and operational implication: The provider’s NPI was enumerated 2009-06-25 (~17 years ago), indicating an established practice history. Given the heavy revenue concentration in anti-VEGF injections and a very large Medicare footprint, the provider’s financials and service volumes would be sensitive to changes in injection protocols, drug mix, or Medicare reimbursement for these high-concentration codes.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
15 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 1,360 | $700 | $948K |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 24,000 | $30 | $696K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,120 | $90 | $180K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 1,370 | $80 | $113.5K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 2,090 | $30 | $58.4K |
| 92235 | The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken… | 480 | $100 | $45.8K |
| 92202 | The provider performs an extended ophthalmoscopy, typically with an indirect ophthalmoscope which utilizes a bright light and a hand–held indirect lens rather than the common hand–held one–piece… | 1,700 | $10 | $18.7K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 160 | $110 | $17.7K |
| J3590 | Unclassified biologics | 230 | $70 | $16.3K |
| 67228 | In retinopathy, tiny new vessels grow profusely and fibrous tissue proliferates in between the layers of the retina, which may extend into the optic nerve and vitreous, clear gel that fills the space… | 40 | $260 | $9.7K |
Showing 1–10 of 15
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 15 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
15 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 20 | 60 | 830 | $690 | $868.8K |
| J2777 | 6 | 40 | 6,750 | $30 | $395.6K |
| 67028 | 23 | 80 | 550 | $80 | $78.6K |
| J3590 | 24 | 50 | 220 | $60 | $24.5K |
| J9035 | 21 | 30 | 200 | $50 | $19.2K |
| 92235 | 3 | 40 | 90 | $100 | $15.8K |
| 99214 | 8 | 10,540 | 110 | $80 | $15.5K |
| 67228 | 10 | 20 | 30 | $230 | $9.8K |
| 67210 | 12 | 10 | 30 | $370 | $8.5K |
| 99213 | 8,771 | 10,820 | 80 | $50 | $7.6K |
Showing 1–10 of 15
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
6 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 190 | $200 | $37.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 320 | $50 | $15.7K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 560 | $20 | $10.6K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 130 | $30 | $4.1K |
| 92202 | The provider performs an extended ophthalmoscopy, typically with an indirect ophthalmoscope which utilizes a bright light and a hand–held indirect lens rather than the common hand–held one–piece… | 240 | $10 | $1.7K |
| 92226 | N/A | 40 | $30 | $1.1K |
How this provider's Medicaid billing volume and revenue compare to other Indiana providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Indiana median
6 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,367 | 2,120 | 870 | $60 | $450.6K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 435 | 690 | 360 | $70 | $110.9K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 41 | 60 | 1,260 | $50 | $108.4K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 47 | 80 | 680 | $20 | $34.5K |
| 92226 | N/A | 7 | 10 | 170 | $10 | $15.6K |
| 92202 | The provider performs an extended ophthalmoscopy, typically with an indirect ophthalmoscope which utilizes a bright light and a hand–held indirect lens rather than the common hand–held one–piece… | 6 | 20 | 110 | $10 | $5.3K |
Other providers in the same ZIP code as Ruchita Amin, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.